This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Solid Tumor
and you are
over 18
years old
1
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

This study is being performed to confirm the safety of tesetaxel 27 mg/m2 (Day 1) in combination with capecitabine 2000/mg/m2/day (in 2 equally divided doses on Days 1 through 14) in a 21-day cycle.

Provided treatments

  • Drug: Tesetaxel plus capecitabine

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01315431. The sponsor of the trial is Genta Incorporated and it is looking for 9 volunteers for the current phase.
Official trial title:
A Phase I Study of Tesetaxel Administered in Combination With Capecitabine to Subjects With Solid Tumors